Insights on the Digestive System Drugs Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global digestive system drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor contributing to the growth of the market during the forecast period is the increasing prevalence of gastrointestinal diseases. This disease is caused due to unhealthy dietary habits. Furthermore, the market is also growing due to rising numbers of clinical trials as well as the increasing healthcare expenditure along with the increasing prevalence of geriatric population.
Digestive diseases include
gastrointestinal disorders such as irritable bowel syndrome (IBS),
constipation, among others. The market is growing owing to new FDA approvals.
For instance, in June 2019, FDA approved Ibsrela, a 50 mg, twice-daily oral
therapy for irritable bowel syndrome with constipation in adults. Additionally,
in June 2019, FDA permitted the marketing of the first medical device to aid in
the reduction of functional abdominal pain. It is used for the treatment of
patients 11-18 years of age with irritable bowel syndrome (IBS).
To Request a Sample of our Report on Digestive System
Drugs Market: https://www.omrglobal.com/request-sample/digestive-system-drugs-market
Some major players in the
market include Abbott Laboratories, AbbVie Inc., and Bayer AG, among others.
The market players are contributing significantly to the growth of the market
by the adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in March 2021,
Knight Therapeutics Inc. announced the commercial availability of IBSRELA
(tenapanor) in Canada. It is a therapy used for the treatment of irritable
bowel syndrome with constipation (IBS-C) in adults.
Market Coverage
• The market number available for –
2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
·
By Drug Type
·
By Dosage Form
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Abbott
Laboratories, AbbVie Inc., and Bayer AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Digestive System Drugs Market is Available @ https://www.omrglobal.com/industry-reports/digestive-system-drugs-market
Global Digestive System Drugs Market Report by Segment
By Drug Type
• Antacids
• Laxatives
• Antidiarrheal agents
• Antiemetics
• Antiulcer agents
• Other
By Dosage Form
• Oral
• Parenteral
• Other
By Application
• Ulcerative Colitis
• Irritable Bowel Syndrome
• Crohn's Disease
• Celiac Disease
• Gastroenteritis
• Other
Global Digestive System Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment